Research into Primary myelofibrosis spans multiple therapeutic approaches and trial phases.

14 total trials for this combination

Showing top 10 of 14 trials

Trials

NCT ID	Title	Status	Phase
NCT01688011	Connect® Myeloid Disease Registry	TERMINATED	—
NCT02124746	Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia	COMPLETED	PHASE2
NCT01178281	Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence	COMPLETED	PHASE3
NCT01236638	Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)	COMPLETED	PHASE2
NCT02530619	Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia	UNKNOWN	NA
NCT00931762	A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis	TERMINATED	PHASE2
NCT04884191	Phase 2 Study: An Open-Label, Randomized, Phase 2 Dose-Finding Study of Pacritinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post- Essential Thrombocythemia Myelofibrosis Previously Treated With Ruxolitinib	COMPLETED	PHASE2
NCT02129101	Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies	COMPLETED	PHASE1
NCT03165734	A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis	ACTIVE_NOT_RECRUITING	—
NCT05320198	Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia	RECRUITING	—

Related Pages

All Primary myelofibrosis trials All trials in Rochester, United States